Summary

Cat Therapeutic Diet Market Summary

The global cat therapeutic diet market size was estimated at USD 1.72 billion in 2024 and is projected to reach USD 3.31 billion by 2033, growing at a CAGR of 7.50% from 2025 to 2033. The market is expanding due to factors such as the humanization of pets, the premiumization of pet nutrition, the increase in lifestyle-related illnesses, veterinary advice, and increased awareness of clinical nutrition.

The humanization of pets continues to influence the cat food market as owners value their cats' well-being and regard them as vital family members. The humanization of pets continues to influence the cat food market as owners value their cats' well-being and regard them as vital family members. According to a January 2025 Forbes report, around 46.5 million households in the United States possess at least one cat, making them a popular companion animal.

The shift of these owners towards pets has accelerated demand for premium therapeutic diets that align with broader consumer trends in wellness and nutrition. The demand for high-end therapeutic meals that follow general consumer trends in nutrition and wellbeing has increased as a result of these owners' transition to pet ownership. The graph below indicates cat ownership by various generation:

The shift of these owners towards pets has accelerated demand for premium therapeutic diets that align with broader consumer trends in wellness and nutrition. The demand for high-end therapeutic meals that follow general consumer trends in nutrition and wellbeing has increased as a result of these owners' transition to pet ownership. High-quality, grain-free, organic, or functional therapeutic meals that prevent or treat chronic illnesses are more expensive for owners. The premiumization trend is influenced by urbanization, rising disposable incomes, and pet parents' heightened health consciousness.

The cat therapeutic diet industry is expanding steadily and robustly because therapeutic diets are now viewed as proactive investments in preventative healthcare rather than just medical interventions. The rising incidence of lifestyle-related diseases in cats, such as diabetes, obesity, kidney difficulties, urinary tract infections, and gastrointestinal disorders, is driving the need for therapeutic diets. Therapeutic diets tailored for weight management, kidney support, or sensitive digestion provide targeted benefits, ensuring better long-term feline health. As awareness of pet health grows, the adoption of condition-specific diets is becoming an essential element of modern feline healthcare.

Veterinary recommendations remain one of the strongest drivers of therapeutic cat diet adoption. When it comes to certain problems like allergies, gastrointestinal sensitivities, or renal disease, pet owners trust the advice of veterinarians. Veterinarian offices frequently serve as important distribution hubs, enhancing the legitimacy and accessibility of these diets. Simultaneously, acceptability is increasing as more people become aware of the role therapeutic nutrition plays in managing and preventing disease through campaigns, instructional materials, and pet care platforms.

In July 2025, Mars Petcare’s announced a new campaign for Whiskas that emphasizes informed feeding by highlighting cats’ unique nutritional needs. Cats need certain, well-balanced meals to maintain their health, unlike dogs. In order to ensure that cats receive scientifically prepared nourishment that is customized to their biological requirements for long-term welfare, the campaign calls on pet parents to go beyond emotional feeding. In order to ensure that cats receive scientifically prepared nourishment that is customized to their biological requirements for long-term welfare, the campaign calls on pet parents to go beyond emotional feeding. Therapeutic diets are seen by owners as essential to long-term care and preventing recurrences.

Global Cat Therapeutic Diet Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the cat therapeutic diet market report based on product, indication, distribution channel, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Wet Food
• Dry Food
• Others
• Indication Outlook (Revenue, USD Million, 2021 - 2033)
• Renal Care
• Obesity Care
• Diabetic Care
• Dental Care
• Gastrointestinal Care
• Recovery Care
• Joint Care
• Oncology Care
• Others
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• E-commerce
• Veterinary hospitals & clinics
• Retail Pharmacies
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o Japan
o India
o China
o South Korea
o Australia
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o UAE
o Kuwait
o Qatar
o Oman

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Cat Therapeutic Diet Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising prevalence of chronic and lifestyle-related conditions
3.2.1.2. Humanization of pets and premiumization of pet nutrition
3.2.1.3. Veterinary influence and expanding clinical nutrition awareness
3.2.2. Market Restraint Analysis
3.2.2.1. High cost and limited accessibility of therapeutic diets
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Cat Therapeutic Diet Market Analysis Tools
3.3.1. Industry Analysis
3.3.1.1. Porter’s Analysis
3.3.1.2. PESTEL Analysis
3.3.2. Regulatory Framework
3.3.3. Pricing Analysis, 2024
3.3.4. Estimated Cat Population, by key countries, 2021 - 2024
Chapter 4. Cat Therapeutic Diet Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Cat Therapeutic Diet Market: Product Movement Analysis
4.3. Cat Therapeutic Diet Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
4.4. Wet Food
4.4.1. Wet Food Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Dry Food
4.5.1. Dry Food Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Others
4.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Cat Therapeutic Diet Market: Indication Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Cat Therapeutic Diet Market: Indication Movement Analysis
5.3. Cat Therapeutic Diet Market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
5.4. Renal Care
5.4.1. Renal Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Obesity Care
5.5.1. Obesity Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Diabetic Care
5.6.1. Diabetic Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Dental Care
5.7.1. Dental Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Gastrointestinal Care
5.8.1. Gastrointestinal Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.9. Recovery Care
5.9.1. Recovery Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.10. Joint Care
5.10.1. Joint Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.11. Oncology Care
5.11.1. Oncology Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.12. Others
5.12.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Cat Therapeutic Diet Market: By Distribution Channel Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Cat Therapeutic Diet Market: By Distribution Channel Movement Analysis
6.3. Cat Therapeutic Diet Market Size & Trend Analysis, by Distribution Channel 2021 to 2033 (USD Million)
6.3.1. E-commerce
6.3.1.1. E-commerce Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.2. Veterinary hospitals & clinics
6.3.2.1. Veterinary hospitals & clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.3. Retail Pharmacies
6.3.3.1. Retail Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Others
6.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Cat Therapeutic Diet Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Cat Therapeutic Diet Market Share, By Region, 2024 & 2033, USD Million
7.3. Regional Outlook
7.4. North America
7.4.1. North America Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. U.S. Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Canada Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Mexico Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5. Europe
7.5.1. Europe Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. UK Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Germany Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. France Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Italy Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Spain Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Denmark Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Sweden Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Norway Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Japan Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. China Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. India Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Australia Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. South Korea Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Thailand Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.7. Latin America
7.7.1. Latin America Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Brazil Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Argentina Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. South Africa Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Saudi Arabia Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. UAE Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Kuwait Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.8.6. Qatar
7.8.6.1. Key Country Dynamics
7.8.6.2. Competitive Scenario
7.8.6.3. Qatar Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.8.7. Oman
7.8.7.1. Key Country Dynamics
7.8.7.2. Competitive Scenario
7.8.7.3. Oman Cat Therapeutic Diet Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Company Market Position Analysis/ Heat Map Analysis
8.3. Company Profiles
8.3.1. Colgate-Palmolive Company
8.3.1.1. Participant’s Overview
8.3.1.2. Financial Performance
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Nestlé
8.3.2.1. Participant’s Overview
8.3.2.2. Financial Performance
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. General Mills Inc.
8.3.3.1. Participant’s Overview
8.3.3.2. Financial Performance
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Virbac
8.3.4.1. Participant’s Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Veterinary Nutrition Group
8.3.5.1. Participant’s Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Farmina Pet Foods
8.3.6.1. Participant’s Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Dechra
8.3.7.1. Participant’s Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Trovet
8.3.8.1. Participant’s Overview
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Vetdiet
8.3.9.1. Participant’s Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. MONGE SPA P.IVA
8.3.10.1. Participant’s Overview
8.3.10.2. Financial Performance
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. FORZA10
8.3.11.1. Participant’s Overview
8.3.11.2. Financial Performance
8.3.11.3. Product Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. Rayne Clinical Nutrition
8.3.12.1. Participant’s Overview
8.3.12.2. Financial Performance
8.3.12.3. Product Benchmarking
8.3.12.4. Strategic Initiatives
8.3.13. Mars Petcare
8.3.14. Mergers & Acquisitions
8.3.15. Partnerships & Collaborations
8.3.16. Product launch
8.3.17. Others
8.4. List of other key players